Simcere Pharmaceutical Shs Sponsored News (NYSE:SCR)
| Latest Simcere Pharmaceutical Shs Sponsored American Deposit Receipt Repr Shs News Headlines | | Date | Time | Source | | | 09/12/2008 | 5:05AM | PRNUS | Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
NANJING, China, Sept. 12 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announces the promotions of Mr. Jindong Zhou and Mr. Xiaojin Yin to Executive... More...>> |
| 09/05/2008 | 12:24AM | PRNUS | /C O R R E C T I O N -- Simcere Pharmaceutical Group/
In the news release, 'Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study', issued on Sept. 3 by Simcere Pharmaceutical Group (NYSE: SCR) over PR Newswire, we are advised by the company that under "Highlights of the interim results of Endu Phase IV clinical study:", a term in the third... More...>> |
| 09/03/2008 | 12:43PM | PRNUS | Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
NANJING, China, Sept. 3 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu (also known as Endostar) in China, announced the interim results of Endu Phase IV clinical... More...>> |
| 08/05/2008 | 7:06AM | PRNUS | Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results
NANJING, China, Aug. 5 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today reported unaudited financial results for the quarter ended June 30, 2008.
Highlights... More...>> |
| 07/15/2008 | 2:33PM | PRNUS | Simcere Pharmaceutical Group to Announce Second Quarter 2008 Earnings on Tuesday, August 5, 2008
NANJING, China, July 15 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and innovative anti-cancer pharmaceuticals in the rapidly growing China market, announced today that it intends to release its 2008 second quarter results... More...>> |
| 06/24/2008 | 10:01AM | PRNUS | Simcere Pharmaceutical Group Files Annual Report on Form 20-F
NANJING, China, June 24 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announced the filing of its annual report on Form 20-F for the year ended... More...>> |
| 05/14/2008 | 10:52AM | PRNUS | Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York
NANJING, China, May 14 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announced that the Company's senior management will present at the following... More...>> |
| 05/14/2008 | 4:30AM | PRNUS | Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
NANJING, China, May 14 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announced that it has received approval from the Chinese State Food and Drug Administration... More...>> |
| 05/06/2008 | 7:50AM | PRNUS | Simcere Pharmaceutical Group Reports Unaudited First Quarter 2008 Results
Net Income Increased 67.5% Year Over Year
NANJING, China, May 6 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today reported unaudited financial results... More...>> |
| 04/28/2008 | 11:34AM | PRNUS | Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip
NANJING, China, April 28 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announced its participation in Credit Suisse's 3rd Annual Healthcare Trip... More...>> |
| 04/28/2008 | 9:43AM | PRNUS | Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
NANJING, CHINA, April 28 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announced that it has been informed that one of its existing shareholders... More...>> |
| 04/15/2008 | 4:15PM | PRNUS | Simcere Pharmaceutical Group to Announce First Quarter 2008 Earnings on Tuesday, May 6, 2008
NANJING, China, April 15 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and innovative anti-cancer pharmaceuticals in the rapidly growing China market, announced today that it intends to release its 2008 first quarter results... More...>> |
| 04/01/2008 | 4:19AM | PRNUS | Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.'s Fourth Investor Tour of China
NANJING, China, April 1, 2008 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announced its participation in Brean Murray, Carret & Co.'s Fourth Investor... More...>> |
| 03/20/2008 | 12:34PM | PRNUS | Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions
NANJING, China, March 20 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announces the appointment of Mr. Mark Chen, Pei-Chi as Vice President of... More...>> |
| 03/04/2008 | 6:25AM | PRNUS | Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
2007 Total Revenue Increased 46.1%, Net Income Rose 75%
NANJING, China, March 4 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer and supplier of the patented anti-cancer product Endu in China, today reported unaudited... More...>> |
| 03/04/2008 | 12:01AM | PRNUS | Endu Receives Gold Medal for Outstanding Chinese Patented Invention Award
NANJING, CHINA, March 4 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, announced today that the company is a gold medal winner of the 10th Outstanding Chinese... More...>> |
| 02/04/2008 | 4:30AM | PRNUS | Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
NANJING, China, Feb. 4 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and innovative anti-cancer pharmaceuticals in the rapidly growing China market, announced today that it intends to release its 2007 fourth quarter results on Tuesday... More...>> |
| 01/14/2008 | 6:15AM | PRNUS | Simcere Pharmaceutical Group to Present at the 8th Annual UBS Greater China Conference
NANJING, China, Jan. 14 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, announced today that it will attend the 8th Annual UBS Greater China Conference to... More...>> |
| 11/05/2007 | 7:13AM | PRNUS | Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
Net Income Increased 73% Year-over-year or 89% Year-to-date
NANJING, China, Nov. 5 /Xinhua-PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group (NYSE:SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today reported... More...>> |
| 10/22/2007 | 12:27PM | PRNUS | Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007
Since Daylight Savings Time (DST) will change to Eastern Standard Time (EST)
effective November 4, please note that the time of the Simcere Q3 conference
call will take place at 9 p.m. (Beijing/Hong Kong time) on November 5, 2007,
while the time of the call in the U.S. remains unchanged at 8 a.m. (EST... More...>> |
|
|
|